Tuesday Dec 3
Analysts: New Cholesterol Treatment Guidelines Present Challenges
Updated guidelines for the treatment of hypercholesterolemia and atherosclerotic cardiovascular disease could well give the statin market a substantial boost over the coming years, but they will pose a significant challenge to developers of other drug classes in the cardiovascular marketplace, according to analysts with research and consulting firm ... (more)
The Motley Fool
3 New Cholesterol Treatments Worth Watching
Nevertheless, statins have been some of the best-selling drugs over the past decade.
Why The New Guidelines Will Endure
This week the discussions about the new cholesterol guidelines from the American College of Cardiology and the American Heart Association took a turn for the worse.
New Statin Guidelines Hit Snag With Faulty Risk Calculator
Those taking statin medications to lower cholesterol need not reduce levels to any specific point, rather they just need to take the correct dose, according to newly released recommendations from the American College of Cardiology and the American Heart Association, The New York Times reports.
The Motley Fool
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
On Tuesday, the American Heart Association and the American College of Cardiology changed the guidelines for the use of LDL cholesterol-lowering statin drugs in patients at risk of heart disease or stroke.
Annual Doctor Visits Will Increase Cholesterol Drug Use
Millions of Americans going for an annual checkup in 2014 will come away from the doctor's office with a new prescription to lower their cholesterol, a move cardiologists say will avert heart attacks and strokes.
UPDATE 1-U.S. heart guidelines threaten hot new cholesterol drugs
New U.S. guidelines on heart health that favor potent statins may threaten future use, or even approval, of a hot new class of experimental cholesterol drugs called PCSK9 inhibitors that have been billed as potential blockbuster treatments, analysts said on Wednesday.
New cholesterol guidelines: The statin decision lies with patients
The release of the new cholesterol guidelines from the ACC/AHA is big news. It represents a fundamental shift in how we prescribe statin drugs.
The Washington Post
Cholesterol Guideline Change Double Drug Treatment
The first U.S. overhaul of guidelines for controlling cholesterol released in a decade may double the number of people on drug therapy while limiting the types of medicine they're prescribed.
New cholesterol guidelines could double number of Americans taking statins
A long-awaited update to cholesterol treatment recommendations was issued Tuesday, and it could lead to a doubling of the number of Americans taking cholesterol-lowering statin drugs from 36 million to 72 million - about 30 percent of US adults.
Small Esperion Vs Pharma Giants In The Cholesterol Race
Esperion Therapeutics , a tiny, Plymouth, Mich based developer of cholesterol drugs, recently started Phase 2b trials of its compound ETC-1002.